The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Booth Bruce since year 2005.
The trader's CIK number is 1451612.
At the time of the last reporting, Booth Bruce was the Director of Magenta Therapeutics, Inc. .
(stock ticker symbol MGTA).
See this page for all insider trading activities at Magenta Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-20||MGTA||Magenta Therapeutics, Inc.||Sale||14,245||17.86||254,415|
|2018-04-03||UMRX||Unum Therapeutics Inc.||Buy||94,052||12.00||1,128,624|
|2018-02-13||MGEN||Miragen Therapeutics, Inc.||Buy||545,454||5.50||2,999,997|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Booth Bruce (Director of Magenta Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.